Mode
Text Size
Log in / Sign up
N/A Completed N=170 Randomized Single-blind Prevention

Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation

Cardiac Catheterization · Radiation Exposure
Source: ClinicalTrials.gov NCT04404257 ↗
Enrolled (actual)
170
Serious AEs
0.6%
Results posted
Jan 2023
Primary outcomePrimary: Radiation Dose to Primary Operator (RaySafe), Cardiac Catheterization — 18; 39 microsievert

Summary

The purpose of this study is to determine whether the ControlRad system device when installed in Fluoroscopic (x-ray) machine reduces radiation dose to operators (Doctors and nurses) and to the patient who is undergoing cardiac Catheterization and electrophysiology (EP) implant procedures.

Outcome Measures

OutcomeResultp-value
PRIMARY
Radiation Dose to Primary Operator (RaySafe), Cardiac Catheterization
18; 39 —
PRIMARY
Radiation Dose to Primary Operator (Luxel Dosimeter), Cardiac Catheterization
18; 41 —
PRIMARY
Radiation Dose to Primary Operator, EP Procedure (Luxel)
21.7; 58.1 —
PRIMARY
Radiation Dose to Primary Operator, EP Procedure (RaySafe)
25; 61 —
SECONDARY
Radiation Dose to Secondary Operator, Cardiac Catheterization (RaySafe)
12; 21 —
SECONDARY
Radiation Dose to Secondary Operator (Luxel Dosimeter), Cardiac Catheterization
13; 26 —
SECONDARY
Radiation Dose to Nurse or Anesthetist, Cardiac Catheterization (RaySafe)
NA; NA —
SECONDARY
Radiation Dose to Nurse or Anesthetist, Cardiac Catheterization (Luxel)
NA; NA —
SECONDARY
Radiation Dose to Patient, Cardiac Catheterization
2276; 3487 —
SECONDARY
Radiation Dose in Cath Lab Room #5, Cardiac Catheterization
15; 25 —
SECONDARY
Radiation Dose to Secondary Operator, EP Procedure (RaySafe)
3; 5 —
SECONDARY
Radiation Dose to Secondary Operator, EP Procedure (Luxel)
1.6; 9 —
SECONDARY
Radiation Dose to Nurse or Anesthetist, EP Procedure (RaySafe)
0; 2 —
SECONDARY
Radiation Dose to Nurse or Anesthetist, EP Procedure (Luxel)
0; 3.8 —
SECONDARY
Radiation Dose to Patient, EP Procedure
43.7; 72.5 —
SECONDARY
Radiation Dose in Cath Lab Room #5, EP Procedure
0; 0 —

Eligibility Criteria

Inclusion Criteria

  • - Patient
  • Scheduled to undergo left heart catheterization with angiography, and/or percutaneous coronary intervention
  • Scheduled to undergo pacemaker or ICD implant
  • EP device upgrade
  • Able to provide written informed consent prior to the procedure
  • Age ≥18 years
  • Physicians and Staff o Able to provide consent for the study

Exclusion Criteria

  • - Patient
  • Cardiogenic shock
  • Reason for cath procedure is pericardiocentesis
  • Subcutaneous ICDs
  • Lead revisions
  • Inability to provide informed consent
  • Pregnant
  • Physicians and Staff
  • Those who are not willing to participate in the study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04404257). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search